Résumés
Résumé
La consommation non appropriée d’anxiolytiques, de sédatifs et d’hypnotiques (ASH) chez les personnes âgées est un problème de santé publique important. Près de 35 % de la population âgée vivant à domicile consomment ces médicaments, en moyenne 206 jours par an. Selon les données québécoises, les personnes âgées de plus de 65 ans consomment cinq fois plus d’ASH que les individus âgés entre 18 et 64 ans. L’utilisation des ASH ne serait pas uniquement déterminée par la présence de symptômes, mais aussi par les caractéristiques psychosociales des sujets. En outre, plusieurs chercheurs ont suggéré que l’entourage et le système de soins étaient des facteurs environnementaux pouvant faciliter ou inhiber la consommation de ces médicaments chez les personnes âgées. Un cadre conceptuel est proposé pour aider à spécifier adéquatement les diverses hypothèses explicatives de ce comportement social de santé et, par conséquent, pour aider à mieux cibler les interventions visant à le modifier.
Abstract
Inappropriate consumption of anxiolytic, sedative and hypnotic medication (ASH) in the elderly is an important public health issue. Almost 35 % of the elderly population living at home take these medications, approximately 206 days per year. According to Quebec data, people who are 65 and older take five times more ASH than people between 18 and 64. The use of ASH would not only be determined by the presence of symptoms, but also by psychosocial characteristics of the subjects. Moreover, several researchers have suggested that the family as well as the health system were environmental factors that could facilitate or inhibit consumption of these medications in the elderly. A conceptual framework is proposed to help specify more adequately the various explanatory hypotheses of this social health behavior and, consequently, better target interventions aiming at its modiffication.
Resumen
El consumo no apropiado de ansiolíticos, sedantes e hipnóticos (ASH) en las personas de edad avanzada es un problema de salud pública importante. Cerca de 35% de la población de edad avanzada que vive en su casa consume estos medicamentos, en promedio 206 días al año. Según los datos quebequenses, las personas de más de 65 años consumen cinco veces más de ASH que los individuos entre 18 y 64 años. La utilización de ASH no está únicamente determinada por la presencia de síntomas, sino también por las características psicosociales de los pacientes. Además, varios investigadores han sugerido que el entorno y el sistema de salud son factores ambientales que pueden facilitar o inhibir el consumo de estos medicamentos en las personas de edad avanzada. Se propone un marco conceptual para ayudar a especificar adecuadamente las diversas hipótesis que explican este comportamiento social de salud y, por consiguiente, para ayudar a identificar mejor las intervenciones que buscan modificarlo.
Resumo
O consumo não apropriado de ansiolíticos, sedativos e soníferos (ASH) em pessoas idosas é um problema de saúde pública importante. Cerca de 35% da população idosa que vive em casa consome estes medicamentos, em média 206 dias por ano. Segundo os dados do Quebec, as pessoas idosas de mais de 65 anos consomem cinco vezes mais ASH que pessoas entre 18 e 64 anos. A utilização dos ASH não seria unicamente determinada pela presença de sintomas, mas também pelas características psicossociais das pessoas. Além disto, vários pesquisadores sugerem que o meio e o sistema de saúde são fatores ambientais que podem facilitar ou dificultar o consumo destes medicamentos em pessoas idosas. Propõe-se um quadro conceitual para ajudar a especificar adequadamente as várias hipóteses explicativas deste comportamento social de saúde, e conseqüentemente, para ajudar a melhor especificar as intervenções que visam modificá-lo.
Parties annexes
Références
- Allard, J. , 1987, Médicaments chez le patient âgé : précautions, Actualité Médicale, 4 mars.
- Allard, J., Allaire, D., Leclerc, G., Langlois, S., 1995, The influence of family and social relationships on the consumption of psychotropic drugs by the elderly, Archives of Gerontology and Geriatrics, 20, 193-204.
- Andersen, R et Newman, J. F. , 1981, Societal and individual determinants of medical care utilization in the United States, in McKinlay, J. B., ed., Health Care Consumers, Professionals and Organizations, Cambridge Mass MIT Press, 88-117.
- Beers, M. H., Fingold, S. F., Ouslander, J. G., Reuben, D. B., Morgenstern, H., Beck, J. C., 1993, Characteristics and quality of prescribing by doctors practicing in nursing homes, Journal of the American Geriatrics Society, 41, 802-807.
- Blazer, D., Hybels, C., Simonsick, E., Hanlon, J. T., 2000, Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years : a racial comparison, Journal of the American Geriatrics Society, 48, 1073-1079.
- Cans, C., Rotily, M. , 1991, La consommation des psychotropes en population générale dans le département de l’Isère, Revue épidémiologique et santé publique, 39, 515-522.
- Campbell, A. J., McCosh, L., Reinkin, J., 1983, Drugs taken by a population based sample of subjects 65 years and over in New Zealand, New Zealand Medical Journal, 96, 378-380.
- Campbell, A. J., Robertson, M. C., Gardner, M. M. , 1995, Elderly people who fall : identifying and managing the causes, British Journal of Hospital Medicine, 54, 10, 520-523.
- Cooperstock, R. , 1978, Sex differences in psychotropic drug use, Social Science and Medicine, 16, 12, 1179-1196.
- Davidson, W., Molloy, W., Somers, G., Bédard, M. , 1994, Relation between physician characteristics and prescribing for elderly people in New Brunswick, Canadian Medical Association Journal, 150, 6, 917-921.
- Dealberto, M. J., Seeman, T., Mcavay, G. J., Berkman, L., 1997, Factors related to current and subsequent psychotropic drug use in an elderly cohort, Journal of Clinical Epidemiology, 50, 3, 357-364.
- Ettorre, E., Klaukka, T., Riska, E., 1994, Psychotropic drugs — long-term use, dependency and the gender factor, Social Science and Medicine, 39, 12, 1667-1673.
- Ferry, M. E., Lamy, P. P., Becker, L. A., 1985, Physicians’ knowledge of prescribing for the elderly. A study of primary care physicians in Pennsylvania, Journal of the American Geriatrics Society, 33, 9, 616-625.
- Folsom, J. C., Boies, B., Pommerenck, K., 1978, Life adjustment techniques for use with the dysfunctional elderly, Ages Care and Services Review, 1, 1-12.
- Glantz, M. , 1981, Predictions of elderly drug abuse, Journal of Psychoactive Drugs, 13, 2, 117-126.
- Gleason, P. P., Schulz, R., Smith, N. L., Newsom, J. T., Kroboth, P., Kroboth, F. J., Psaty, B. M., 1998, Correlates and prevalence of benzodiazepine use in community-dwelling elderly, Journal of General Internal Medicine, 13, 4, 243-250.
- Gouvernement du Québec, 1992, La politique de la santé et du bien-être, Québec.
- Graham, K., Vidalzeballos, D., 1998, Analyses of use of tranquilizers and sleeping pills across five surveys of the same population (1985-1991) — the relationship with gender, age and use of other substances, Social Science and Medicine, 46, 3, 381-395.
- Grymonpre, R. E., Mitenko, P. A., Sitar, D. S., Aoki, F. Y., Montgomery, P. R., 1988, Drug-associated hospital admissions in older medical patients, Journal of the American Geriatrics Society, 36, 1092-1098.
- Gustafsson, T.M., Thorslund, M., Sörbom, D., 1996, Factors associated with psychotropic drug use among the elderly living at home, The Journal of Applied Gerontology, 15, 2, 238-254.
- Haayer, F., 1982, Rational prescribing and sources of information, Social Science and Medicine, 16, 23, 2017-2023.
- Hanlon, J. T., Cutson, T., Ruby, C. M., 1996, Drug-related falls in the older adult, Topics in Geriatric Rehabilitation, 11, 3, 38-54.
- Harrington, C., Tompkins, C., Curtis, M., Grant, L., 1992, Psychotropic drug use in long-term care facilities : a review of the literature, The Gerontologist, 32, 6, 822-833.
- Hébert, R. , 1984, Le médecin : un pusher légal ? In Toxicomanie et troisième âge. Les cahiers des journées de formation annuelle du Sanatorium Bégin, 35-42.
- Hébert, R. , 1991, La prescription d’un médicament, in Barbeau, G. Guimond, J. et Mallet, L., eds., Médicaments et personnes âgées, Edisem et Maloine.
- Isacson, D. , 1992, Long-term use of benzodiazepines in a Swedish community : an eight follow-up, Journal of Clinical Epidemiology, 45, 4, 429-436.
- Isacson, D., Bingefors, K., Wennberg, M., Dahlström, M., 1993, Factors associated with high-quantity prescriptions of benzodiazepines in Sweden, Social Science and Medicine, 36, 3, 343-351.
- Jorm, A. F., Grayson, D., Creasey, H., Waite, L., Broe, G. A., 2000, Long-Term benzodiazepine use by elderly people living in the community, Australian and New Zealand Journal of Public Health, 24, 1, 7-10.
- Kern, K. , 1990, Some aspects of doctor-patient relationships and the older patient, Zeitschrift Fur Gerontologie, 23, 354-360.
- Laurier, C., Dumas, J., Grégoire, J. P., 1992, Factors related to benzodiazepine use in Quebec : A secondary analysis of survey data, Journal of Pharmacoepidemiology, 2, 4, 73-86.
- Linn, B. S., Linn, M. W., 1982, Patient symptoms and physician prescribing patterns in the elderly, Social Science and Medicine, 16, 1531-1538.
- McKiM, W. A., Mishara, B. , 1987, Drugs and Aging, Butterwortle, Toronto.
- Mechanic, D. , 1978, Medical Sociology, New York, The Free Press.
- Mechanic, D. , 1986, The concept of illness behavior : culture, situation and personal predisposition, Psychological Medicine, 16, 1-7.
- Morse, R. M. , 1988, Substance abuse among the elderly, Bulletin of the Menninger Clinic, 52, 3, 259-268.
- Mort, J. R., Aparasu, R. R. , 2000, Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly, Archives of Internal Medicine 160, 18, 2825-2831.
- Osterweis, M., Bush, P. J., Zuckermen, A. E. , 1979, Family context as a predictor of medicine use, Social Science and Medicine, 13A, 287-291.
- Paterniti, S., Dufouil, C., Alpérovitch, A. , 2002, Long-term benzodiazepine use and cognitive decline in the elderly : the epidemiology of vascular aging study, Journal of Clinical Psychopharmacology, 22, 3, 285-293.
- Pérodeau, G. M., King, S., Ostoj, M. , 1992, Stress and psychotropic drug use among the elderly : an exploratory model, Canadian Journal on Aging, 11, 4, 347-369.
- Pollock, B. G. , 1997, Gender differences in psychotropic drug metabolism, Psychopharmacology Bulletin, 33, 2, 235-241.
- Préville, M., Hébert, R., Boyer, R., Bravo, G. , 2001, Correlates of psychotropic drug use in the elderly compared to adults aged 18-64 : results from the Quebec health survey, Aging and Mental Health, 5, 3, 216-224.
- Préville, M., Hébert, R., Boyer, R., Bravo, G. , 2002, Predisposing and facilitating factors of severe psychological distress among frail elderly, Canadian Journal on Aging, 21, 2, 195-204.
- Préville, M., Hébert, R., Allard, J., Grégoire, J. P., Bédard, A., Fortin, D., Ducharme, C., Trottier, L. , 2002a, Facteurs associés à l’utilisation des psychotropes chez les personnes âgées vivant dans la communauté, Rapport de recherche du Centre de recherche sur le vieillissement de l’Institut universitaire de gériatrie de Sherbrooke. ISBN 2-92-1470-38-1.
- Régie De l’assurance-maladie du Québec, 1992, Rapport du comité d’analyse de la consommation médicamenteuse des personnes âgées, Régie de l’assurance-maladie, Québec.
- Régie De l’assurance-maladie du Québec, 2000, Statistiques annuelles.
- Régie De l’assurance-maladie du Québec, 2001, Portrait quotidien de la consommation médicamenteuse des personnes âgées non hébergées.
- Régie De l’assurance-maladie du Québec, 2001a, Nombre de participants et d’ordonnances, nombre d’ordonnances par participant, coût brut des ordonnances et par participant, coût RAMQ des ordonnances et par participant selon la classe des médicaments et la catégorie de personnes assurées, régime d’assurance médicaments. Statistiques (document Internet : http://www.ramq.gouv.qc.ca/crc/sta/cout/assmed01.shtml.
- Reid, L. D., Christensen, D. B., Stergachis, A. , 1990, Medical and psychological factors predictive of psychotropic drug use in elderly patients, American Journal of Public Health, 80, 11, 1349-1353.
- Robitaille, L., Courchesne, M., Sylvain, J., Vadnais, M. , 1991, Anxiolytiques et hypnotiques, in Barbeau, G., Guimond, J., Mallet, L., eds., Médicaments et personnes âgées, Edisen et Maloine.
- Salinsky, J. V., Doré, C. J. , 1987, Characteristics of long term benzodiazepine users in general practice, Journal of Royal College of General Practitioners, 37, 202-204.
- Salzman, C., Nevis-Olesen, J. , 1992, Psychopharmacologic treatment, in Birren, J. E., Sloane, R.B., Cohen, G.D., eds., Handbook of Mental Health and Aging, San Diego, Harcourt Brace Jovanovich, Academic Press.
- Schwartz, R. K., Soumerai, S. B., Avorn, J. , 1989, Physician motivations for non scientific drug prescribing, Social Science and Medicine, 28, 6, 577-582.
- Shelowitz, P. A. , 1987, Drug use, misuse and abuse among elderly, Medicine and Law, 6, 235.
- Smart, R. G., Adalf, E. M. , 1988, Alcohol and drug use among the elderly : trends in use and characteristics of users, Canadian Journal of Public Health, 79, 4, 236-242.
- Stewart, R. B. , 1988, Drug use in the elderly, in Delfuente, J.C. et Stewart, R.B., eds., Therapeutics in the Elderly, Baltimore, William and Wilkins, 50-63.
- Swartz, M., Landerman, R., George, L. K., Melville, M. L., Blazer, D., Smith, K. , 1991, Benzodiazépine anti-anxiety agents : Prevalence and correlates of use in a Southern community, American Journal of Public Health, 81, 592-596.
- Tamblyn, R. M., McLeod, P. J., Abrahamowicz, M., Monette, J., Gayton, D. C., Berkson, L., Dauphinee, W. D., Grad, R. M., Huang, A. R., Isaac, L. M., Schnarch, B. S., Snell, L. S. , 1994, Questionable prescribing for elderly patients in Quebec, Canadian Medical Association Journal, 150, 11, 1801-1809.
- Tamblyn, R. , 1996, Medication use in seniors : challenges and solutions, Thérapie, 51, 269-282.
- Tamblyn, R. M., McLeod, P. J., Abrahamowicz, M., LAPRISE, R. , 1996b, Do too many cooks spoil the broth — multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations, Canadian Medical Association Journal, 154, 8, 1177-1184.
- Taylor, S., McCracken, C. F. M., Wilson, K. C. M., Copeland, J. R. M. , 1998, Extent and appropriateness of benzodiazepine use. Results from an elderly urban community sup (dagger), The British Journal of Psychiatry, 173, 11, 433-438.
- Thapa, P. B., Gideon, P., Fought, R. L., Ray, W. A. , 1995, Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents, American Journal of Epidemiology, 142, 2, 202-211.
- Weyerer, S., Dilling, H. , 1991, Psychiatric and physical illness, sociodemographic characteristics, and the use of psychotropic drugs in the community : results from the upper bavarian field study, Jounal of Clinical Epidemiology, 44, 3, 303-311.
- Williamson, J., Chopin, J. M. , 1980, Adverse reactions to prescribed drugs in the elderly : a multicenter investigation, Age and Ageing, 9, 2, 73-80.